NASDAQ: IVCAInvestcorp India Acquisition Corp Stock
$11.22+0.00 (+0%)
Updated Apr 18, 2024
IVCA Price
$11.22
Fair Value Price
N/A
Market Cap
$182.42M
52 Week Low
$10.55
52 Week High
$11.31
P/E
33x
P/B
-88.33x
P/S
N/A
PEG
2.63x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$8.86M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.23
Operating Cash Flow
-$659k
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
IVCA Overview
Investcorp India Acquisition Corp focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on completing a business combination with a business in any of the consumer, financial, technology, technology-enabled, healthcare, or media sectors primarily in India. The company was formerly known as Investcorp Acquisition Corp. and changed its name to Investcorp India Acquisition Corp in January 2022. Investcorp India Acquisition Corp was incorporated in 2021 and is based in George Town, the Cayman Islands.
Zen Score
–
Industry Average (8)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IVCA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IVCA ($11.22) is trading above its intrinsic value of $3.36, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IVCA is good value based on its earnings relative to its share price (33x), compared to the US market average (41.33x)
P/E vs Market Valuation
IVCA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more IVCA due diligence checks available for Premium users.
Be the first to know about important IVCA news, forecast changes, insider trades & much more!
IVCA News
Valuation
IVCA fair value
Fair Value of IVCA stock based on Discounted Cash Flow (DCF)
Price
$11.22
Fair Value
$11.08
Overvalued by
1.24%
IVCA ($11.22) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
IVCA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
33x
Industry
34.4x
Market
41.33x
IVCA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IVCA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
IVCA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-88.33x
Industry
-14.07x
IVCA price to earnings growth (PEG)
For valuing profitable companies with growth potential
IVCA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
IVCA's financial health
Profit margin
Revenue
$0.0
Net Income
$2.1M
Profit Margin
0%
IVCA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$108.5M
Liabilities
$2.5M
Debt to equity
-1.23
IVCA's short-term liabilities ($1.66M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IVCA's long-term liabilities ($870.75k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IVCA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IVCA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$53.6k
Investing
-$300.0k
Financing
$600.0k
IVCA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
IVCA vs Shell Company Stocks
Investcorp India Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.